Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians
Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, Eisenhauer E, Bacon M, Tu D, Parmar MK, Amos C, Murray C, Qian W (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 373 (9658): 137–146.
Google Scholar
Bray F, Loos AH, Oostindier M, Weiderpass E (2005) Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe. Int J Cancer 117 (1): 123–131.
Google Scholar
Cassileth BR, Zupkis RV, Sutton-Smith K, March V (1980) Information and participation preferences among cancer patients. Ann Intern Med 92 (6): 832–836.
Google Scholar
Chapple A, Ziebland S, Herxheimer A, McPherson A, Shepperd S, Miller R (2002) Is ‘watchful waiting’ a real choice for men with prostate cancer? A qualitative study. BJU Int 90 (3): 257–264.
Google Scholar
Charles C, Redko C, Whelan T, Gafni A, Reyno L (1998) Doing nothing is no choice: lay constructions of treatment decision-making among women with early-stage breast cancer. Sociol Health Illn 20 (1): 71–95.
Google Scholar
Creutzberg CL, Nout RA (2012) [The PORTEC-4 trial: phase III randomised trial investigating the role and dose of vaginal brachytherapy for endometrial carcinoma]. Nederlands Tijdschrift voor Oncologie 9 (4): 183–187.
Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, Steen-Banasik E, Beerman H, van Lent M (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355 (9213): 1404–1411.
Google Scholar
Degner LF, Sloan JA, Venkatesh P (1997) The Control Preferences Scale. Can J Nurs Res 29 (3): 21–43.
Google Scholar
Fowler FJ Jr, McNaughton CM, Albertsen PC, Zietman A, Elliott DB, Barry MJ (2000) Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 283 (24): 3217–3222.
Google Scholar
Gurmankin AD, Baron J, Hershey JC, Ubel PA (2002) The role of physicians’ recommendations in medical treatment decisions. Med Decis Making 22 (3): 262–271.
Google Scholar
Jansen SJ, Kievit J, Nooij MA, de Haes JC, Overpelt IM, van SH, Maartense E, Stiggelbout AM (2001) Patients’ preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile? Br J Cancer 84 (12): 1577–1585.
Google Scholar
Jansen SJ, Otten W, Stiggelbout AM (2004) Review of determinants of patients’ preferences for adjuvant therapy in cancer. J Clin Oncol 22 (15): 3181–3190.
Google Scholar
Jenkins V, Fallowfield L, Saul J (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84 (1): 48–51.
Google Scholar
Kennedy ED, Schmocker S, Victor C, Baxter NN, Kim J, Brierley J, McLeod RS (2011) Do patients consider preoperative chemoradiation for primary rectal cancer worthwhile? Cancer 117 (13): 2853–2862.
Google Scholar
Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92 (3): 744–751.
Google Scholar
Llewellyn-Thomas HA (1997) Investigating patients’ preferences for different treatment options. Can J Nurs Res 29 (3): 45–64.
Google Scholar
Montgomery AA, Fahey T (2001) How do patients’ treatment preferences compare with those of clinicians? Qual Health Care 10 (Suppl 1): i39–i43.
Google Scholar
Moreau A, Carol L, Dedianne MC, Dupraz C, Perdrix C, Laine X, Souweine G (2012) What perceptions do patients have of decision making (DM)? Toward an integrative patient-centered care model. A qualitative study using focus-group interviews. Patient Educ Couns 87 (2): 206–211.
Google Scholar
Moumjid N, Gafni A, Bremond A, Carrere MO (2007) Shared decision making in the medical encounter: are we all talking about the same thing? Med Decis Making 27 (5): 539–546.
Google Scholar
Muller-Engelmann M, Keller H, Donner-Banzhoff N, Krones T (2011) Shared decision making in medicine: the influence of situational treatment factors. Patient Educ Couns 82 (2): 240–246.
Google Scholar
Nout RA, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Stenfert Kroese MC, Nijman HW, van de Poll-Franse LV, Creutzberg CL (2012) Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. Eur J Cancer 48 (11): 1638–1648.
Google Scholar
Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Kroese MC, van Bunningen BN, Ansink AC, van Putten WL, Creutzberg CL (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375 (9717): 816–823.
Google Scholar
Pieterse AH, Stalmeier PF, Kroep JR, Stiggelbout AM (2011) [Adjuvant cancer treatment: what benefit does the patient consider worthwhile?]. Ned Tijdschr Geneeskd 155 (45): A3905.
Google Scholar
Pieterse AH, Stiggelbout AM, Baas-Thijssen MC, van de Velde CJ, Marijnen CA (2007) Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients’ and oncologists’ preferences. Br J Cancer 97 (6): 717–724.
Google Scholar
Salkeld G, Solomon M, Short L, Butow PN (2004) A matter of trust—patient’s views on decision-making in colorectal cancer. Health Expect 7 (2): 104–114.
Google Scholar
Stalmeier PF, van Tol-Geerdink JJ, van Lin EN, Schimmel E, Huizenga H, van Daal WA, Leer JW (2007) Doctors’ and patients’ preferences for participation and treatment in curative prostate cancer radiotherapy. J Clin Oncol 25 (21): 3096–3100.
Google Scholar
Stiggelbout AM, de Haes JC, van de Velde CJ (2000) Adjuvant chemotherapy in node negative breast cancer: patterns of use and oncologists’ preferences. Ann Oncol 11 (5): 631–633.
Google Scholar
Stiggelbout AM, Jansen SJ, Otten W, Baas-Thijssen MC, van SH, van de Velde CJ (2007) How important is the opinion of significant others to cancer patients’ adjuvant chemotherapy decision-making? Support Care Cancer 15 (3): 319–325.
Google Scholar
Thomas GM (2010) A role for adjuvant radiation in clinically early carcinoma of the endometrium? Int J Gynecol Cancer 20 (11 Suppl 2): S64–S66.
Google Scholar
van Tol-Geerdink JJ, Stalmeier PF, van Lin EN, Schimmel EC, Huizenga H, van Daal WA, Leer JW (2006) Do patients with localized prostate cancer treatment really want more aggressive treatment? J Clin Oncol 24 (28): 4581–4586.
Google Scholar
Wong J, Szumacher E (2012) Patients’ decision-making in radiation oncology. Expert Rev Pharmacoecon Outcomes Res 12 (1): 95–104.
Google Scholar
Wright J, Jones G, Whelan T, Lukka H (1994) Patient preference for high or low dose rate brachytherapy in carcinoma of the cervix. Radiother Oncol 33 (3): 187–194.
Google Scholar
link
